Capital World Investors Boosts Stock Position in Corteva, Inc. $CTVA

Capital World Investors grew its holdings in Corteva, Inc. (NYSE:CTVA) by 0.1% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 23,240,070 shares of the company’s stock after purchasing an additional 25,009 shares during the period. Capital World Investors’ holdings in Corteva were worth $1,571,726,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Vanguard Group Inc. boosted its stake in shares of Corteva by 0.5% during the second quarter. Vanguard Group Inc. now owns 80,188,326 shares of the company’s stock valued at $5,976,436,000 after purchasing an additional 373,680 shares during the period. Geode Capital Management LLC lifted its holdings in Corteva by 1.4% during the 2nd quarter. Geode Capital Management LLC now owns 18,047,263 shares of the company’s stock valued at $1,339,651,000 after buying an additional 251,693 shares in the last quarter. Franklin Resources Inc. lifted its holdings in Corteva by 4.9% during the 2nd quarter. Franklin Resources Inc. now owns 17,680,238 shares of the company’s stock valued at $1,317,708,000 after buying an additional 824,451 shares in the last quarter. Norges Bank purchased a new stake in Corteva in the 2nd quarter valued at about $434,220,000. Finally, Legal & General Group Plc boosted its position in Corteva by 14.3% in the 3rd quarter. Legal & General Group Plc now owns 5,753,982 shares of the company’s stock valued at $389,142,000 after buying an additional 720,469 shares during the period. 81.54% of the stock is currently owned by institutional investors.

Corteva Stock Up 1.8%

Shares of Corteva stock opened at $78.36 on Tuesday. The company has a quick ratio of 0.96, a current ratio of 1.43 and a debt-to-equity ratio of 0.07. The company has a market cap of $52.70 billion, a P/E ratio of 49.59, a PEG ratio of 2.63 and a beta of 0.72. The firm’s 50 day moving average price is $73.22 and its 200-day moving average price is $69.04. Corteva, Inc. has a 52-week low of $53.40 and a 52-week high of $80.90.

Corteva (NYSE:CTVA) last posted its earnings results on Tuesday, February 3rd. The company reported $0.22 EPS for the quarter, meeting analysts’ consensus estimates of $0.22. The company had revenue of $3.91 billion during the quarter, compared to analysts’ expectations of $4.23 billion. Corteva had a net margin of 6.29% and a return on equity of 9.06%. Corteva’s revenue for the quarter was down 1.7% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.32 earnings per share. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, sell-side analysts predict that Corteva, Inc. will post 2.96 EPS for the current fiscal year.

Corteva Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, March 16th. Stockholders of record on Monday, March 2nd will be issued a dividend of $0.18 per share. This represents a $0.72 annualized dividend and a dividend yield of 0.9%. The ex-dividend date is Monday, March 2nd. Corteva’s dividend payout ratio is currently 45.57%.

Insider Buying and Selling at Corteva

In related news, insider Brian Titus sold 8,311 shares of the business’s stock in a transaction on Friday, February 20th. The stock was sold at an average price of $76.55, for a total transaction of $636,207.05. Following the transaction, the insider directly owned 8,090 shares in the company, valued at $619,289.50. The trade was a 50.67% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 0.15% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CTVA shares. Oppenheimer set a $86.00 price target on shares of Corteva in a research note on Thursday, February 5th. The Goldman Sachs Group reissued a “buy” rating and issued a $88.00 price objective on shares of Corteva in a research note on Thursday, February 5th. Royal Bank Of Canada lifted their target price on Corteva from $80.00 to $89.00 and gave the company an “outperform” rating in a research report on Thursday, February 5th. UBS Group cut Corteva from a “buy” rating to a “hold” rating in a report on Monday, February 9th. Finally, Jefferies Financial Group increased their price target on Corteva from $85.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, March 2nd. One equities research analyst has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, Corteva has an average rating of “Moderate Buy” and a consensus price target of $82.90.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.